[HTML][HTML] A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis
CL Andersen, NB Mortensen, TW Klausen… - …, 2014 - ncbi.nlm.nih.gov
The Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) primary
myelofibrosis (PMF) is characterized by progressive accumulation of connective tissue and
endothelial proliferation in the bone marrow accompanied by extramedullary hematopoiesis
with enlargement of the spleen and liver. 1, 2 Patients with PMF have a poor prognosis with
a median survival of 6.5 years. 3 When myelofibrosis develops during the course of
polycythemia vera (PV) and essential thrombocythemia (ET), the conditions are termed post …
myelofibrosis (PMF) is characterized by progressive accumulation of connective tissue and
endothelial proliferation in the bone marrow accompanied by extramedullary hematopoiesis
with enlargement of the spleen and liver. 1, 2 Patients with PMF have a poor prognosis with
a median survival of 6.5 years. 3 When myelofibrosis develops during the course of
polycythemia vera (PV) and essential thrombocythemia (ET), the conditions are termed post …
[引用][C] A Phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera myelofibrosis (PPV-MF)
CL Andersen, N Mortensen, H Vestergaard… - 2013 - portal.findresearcher.sdu.dk
A Phase II study of Vorinostat (MK-0683) in Patients with Primary Myelofibrosis (PMF) and
Post-Polycythaemia Vera Myelofibrosis (PPV-MF) — University of Southern Denmark … A
Phase II study of Vorinostat (MK-0683) in Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia
Vera Myelofibrosis (PPV-MF) …
Post-Polycythaemia Vera Myelofibrosis (PPV-MF) — University of Southern Denmark … A
Phase II study of Vorinostat (MK-0683) in Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia
Vera Myelofibrosis (PPV-MF) …